Stay updated on Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA notice about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” appears at the top of the page.SummaryDifference0.7%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision label v3.7.0 was added to the study record history and the previous revision v3.6.6 was removed, reflecting an update to the page's revision history rather than substantive data changes.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry, v3.6.6, has been added to the record history. The previous v3.6.5 entry has been removed, updating the version list shown for the study record.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.